Sign up
Quantellect · Congress · Issuer Profile
NASDAQ: BIIBBiogen Inc
HealthcareMkt Cap $37.46BCongress ownership rank #100

Biogen Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 211 trades in Biogen Inc (NASDAQ: BIIB) since 2012, across 38 members, worth an estimated $2.5M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 114 buys against 97 sells, a modestly buy-led skew, with Democratic members responsible for 55% of the trades and Republican members 45%. The most recent disclosure shown was filed October 2026, and Rohit Khanna has filed the most BIIB transactions among those shown, with 7. Other recent filers include Maria Elvira Salazar, Kevin Hern, and Gilbert Cisneros. One notable disclosed move was a purchase by Rohit Khanna on January 29, 2026, up 42.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Biogen Inc's current Quantellect Tide Score is 51 out of 100 (High Tide), Top 49% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Biogen Inc (BIIB) stock overview and the complete trade table below.

Data updated

Trades
16
Politicians
5
Filings
11
Disclosed Vol
$219.51K
Buys
9
56%
Sells
7
44%

Price & congressional trade timeline

Party breakdown

Biogen congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Oct 7, 2026Sep 24, 202613 daysSell
$1,001 - $15,000
+11.07%Self
Oct 7, 2026Sep 11, 202626 daysSell
$1,001 - $15,000
+15.78%Child
Oct 7, 2026Sep 4, 202633 daysBuy
$1,001 - $15,000
+13.85%Spouse
Sep 1, 2026Aug 18, 202614 daysSell
$1,001 - $15,000
+18.28%Self
Jul 2, 2026Jun 5, 202627 daysBuy
$1,001 - $15,000
+28.70%Self
Jul 7, 2026Jun 2, 202635 daysSell
$15,001 - $50,000
+33.14%Self
Jun 9, 2026May 27, 202613 daysSell
$1,001 - $15,000
+27.64%Spouse
Jun 9, 2026May 15, 202625 daysBuy
$1,001 - $15,000
+30.30%Spouse
Jun 8, 2026May 12, 202627 daysBuy
$1,001 - $15,000
+26.11%Self
Jun 8, 2026May 11, 202628 daysBuy
$1,001 - $15,000
+27.01%Self
Go to

Biogen (BIIB) congressional trading FAQ

Can members of Congress legally trade Biogen (BIIB) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Biogen (BIIB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Biogen (BIIB) trades public?

Yes. Every congressional trade in Biogen (BIIB) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Biogen (BIIB)?

Members of Congress have disclosed 211 trades in Biogen (BIIB) worth $2.5M across 38 members, according to public STOCK Act filings.

Which members of Congress have traded Biogen (BIIB)?

Recent and active filers of Biogen (BIIB) disclosures include Rohit Khanna, Maria Elvira Salazar, Gilbert Cisneros. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Biogen (BIIB) more?

Across disclosed Biogen (BIIB) trades, 55% were by Democrats and 45% by Republicans, led by Democrats (55%).

What is the most recent congressional Biogen (BIIB) trade?

The most recent disclosed Biogen (BIIB) filing reported a buy by Rohit Khanna, filed Oct 6, 2026.

What is Biogen (BIIB)'s Tide Score?

Biogen (BIIB) has a Quantellect Tide Score of 51 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewBiogen (BIIB) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.